Despite challenges in the home health sector, Humana remains confident in CenterWell’s ability to drive enterprise-wide ...

Humana (HUM) stock jumps as the company with its Q2 results lifts its 2025 outlook, citing strength in its Medicare Advantage ...

Humana raised its full-year outlook as it anticipates a smaller decline in Medicare Advantage membership than originally ...

Humana's Q2 earnings fall year over year on a declining membership base. Notably, 2025 adjusted EPS is currently forecasted ...

Humana lowered its full-year 2025 GAAP EPS guidance to approximately $13.77, down from $14.68. At the same time, it raised ...

Humana raised its annual profit forecast after beating quarterly estimates on Wednesday, as the U.S. health insurer succeeded ...

Humana's Q2 2025 earnings showcase raised EPS guidance, driven by CenterWell Pharmacy outperformance and MA membership gains.

Humana is raising its full-year guidance after surpassing revenue expectations in the second quarter, the insurer announced ...

Humana Inc. reports second quarter 2025 financial results with earnings per share (EPS) slightly below expectations.

Humana raised its annual profit forecast on Wednesday, as the U.S. health insurer bets on its efforts to rein in higher ...